Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia

Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia

<p>Abstract</p> <p>Background</p> <p>Although most guidelines recommend the use of cholinesterase inhibitors (ChEIs) for mild to moderate Alzheimer's Disease, only a small proportion of affected patients receive these drugs. We aimed to study if geriatric comorbidi...

Full description

Bibliographic Details
Main Authors: Hoffmann Falk, van den Bussche Hendrik, Wiese Birgitt, Schön Gerhard, Koller Daniela, Eisele Marion, Glaeske Gerd, Scherer Martin, Kaduszkiewicz Hanna
Format: Article
Language:English
Published: BMC 2011-12-01
Series:BMC Psychiatry
Online Access:http://www.biomedcentral.com/1471-244X/11/190

Internet

http://www.biomedcentral.com/1471-244X/11/190

Similar Items